SANES

10.706

+1.04%↑

BBVA

19.61

+0.1%↑

BNP

93.65

+0.42%↑

CABK

11.525

+0.09%↑

INGA

26.3

-0.15%↓

SANES

10.706

+1.04%↑

BBVA

19.61

+0.1%↑

BNP

93.65

+0.42%↑

CABK

11.525

+0.09%↑

INGA

26.3

-0.15%↓

SANES

10.706

+1.04%↑

BBVA

19.61

+0.1%↑

BNP

93.65

+0.42%↑

CABK

11.525

+0.09%↑

INGA

26.3

-0.15%↓

SANES

10.706

+1.04%↑

BBVA

19.61

+0.1%↑

BNP

93.65

+0.42%↑

CABK

11.525

+0.09%↑

INGA

26.3

-0.15%↓

SANES

10.706

+1.04%↑

BBVA

19.61

+0.1%↑

BNP

93.65

+0.42%↑

CABK

11.525

+0.09%↑

INGA

26.3

-0.15%↓

Home・Список акций・Eurazeo SE

Eurazeo SE

Закрыт

СекторФинансы

44.14 -1.52

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

43.02

Макс.

44.5

Ключевые показатели
By Trading Economics
Доход	214M -95M
Продажи	372M 283M
Прибыль на акцию	-1.807
Дивидендная доходность	6.31
Рентабельность продаж	-33.447
Сотрудники	578
EBITDA	-256M

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+61.61% upside

Дивиденды
By Dow Jones
Дивидендная доходность Средняя по отрасли	6.31% 4.65%
Следующий отчет о доходах	23 июл. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	122M 3B
Предыдущая цена открытия	45.66
Предыдущая цена закрытия	44.14

Новостные настроения

By Acuity

53%

47%

349 / 439 Рейтинг в Finance

Eurazeo SE График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

3 июн. 2026 г., 23:22 UTC

Отчет

Главные движущие силы рынка

Broadcom Shares Slide Despite Jump in 2Q Revenue on AI Chip Demand -- Update

3 июн. 2026 г., 23:09 UTC

Сравнение c конкурентами

Изменение цены

Eurazeo SE Прогноз

Целевая цена

By TipRanks

61.61% рост

Прогноз на 12 месяцев

Средняя 72.5 EUR 61.61%

Максимум 85 EUR

Минимум 60 EUR

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Eurazeo SE на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

2 ratings

Покупка

Удержание

Продажа

Основано на мнении 2 аналитиков, присваивавших рейтинги акциям Eurazeo SE – Данные за последние 3 месяца.

Настроения

By Acuity

349 / 439Рейтинг в Финансы

Финансовые показатели

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Eurazeo SE

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies. The company invest in equity in the small-mid and Mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in United States, France, Italy, North America and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) to "100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between "1 million ($1.17 million) and "559.01 mil